JP2012506442A5 - - Google Patents

Download PDF

Info

Publication number
JP2012506442A5
JP2012506442A5 JP2011533273A JP2011533273A JP2012506442A5 JP 2012506442 A5 JP2012506442 A5 JP 2012506442A5 JP 2011533273 A JP2011533273 A JP 2011533273A JP 2011533273 A JP2011533273 A JP 2011533273A JP 2012506442 A5 JP2012506442 A5 JP 2012506442A5
Authority
JP
Japan
Prior art keywords
scar
adhesion
existing
use according
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011533273A
Other languages
English (en)
Japanese (ja)
Other versions
JP5785085B2 (ja
JP2012506442A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/061345 external-priority patent/WO2010065206A1/en
Publication of JP2012506442A publication Critical patent/JP2012506442A/ja
Publication of JP2012506442A5 publication Critical patent/JP2012506442A5/ja
Application granted granted Critical
Publication of JP5785085B2 publication Critical patent/JP5785085B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011533273A 2008-10-20 2009-10-20 癒着を処置又は防止するためのポリペプチド Expired - Fee Related JP5785085B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10683408P 2008-10-20 2008-10-20
US61/106,834 2008-10-20
PCT/US2009/061345 WO2010065206A1 (en) 2008-10-20 2009-10-20 Polypeptide for treating or preventing adhesions

Publications (3)

Publication Number Publication Date
JP2012506442A JP2012506442A (ja) 2012-03-15
JP2012506442A5 true JP2012506442A5 (enExample) 2012-12-06
JP5785085B2 JP5785085B2 (ja) 2015-09-24

Family

ID=42108870

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011533273A Expired - Fee Related JP5785085B2 (ja) 2008-10-20 2009-10-20 癒着を処置又は防止するためのポリペプチド

Country Status (11)

Country Link
US (1) US9034815B2 (enExample)
EP (1) EP2349310B1 (enExample)
JP (1) JP5785085B2 (enExample)
KR (2) KR101884616B1 (enExample)
CN (1) CN102256613B (enExample)
AU (1) AU2009322865B2 (enExample)
BR (1) BRPI0919759A2 (enExample)
CA (1) CA2741302C (enExample)
DK (1) DK2349310T3 (enExample)
ES (1) ES2507496T3 (enExample)
WO (1) WO2010065206A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2594281T3 (es) 2007-01-10 2016-12-19 Purdue Research Foundation Inhibidores polipeptídicos de HSP27 quinasa y usos de los mismos
DK2185698T3 (en) * 2007-08-07 2015-07-27 Purdue Research Foundation Kinase Inhibitors and Uses thereof
US9327008B2 (en) 2008-12-10 2016-05-03 Purdue Research Foundation Cell-permeant peptide-based inhibitor of kinases
US9890195B2 (en) 2009-07-27 2018-02-13 Purdue Research Foundation MK2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
EP2575855A4 (en) * 2010-05-24 2014-03-12 Moerae Matrix Inc METHOD FOR TREATING OR PREVENTING VASCULAR GRAFT BREAKAGE
US9890200B2 (en) 2011-04-12 2018-02-13 Moerae Matrix, Inc. Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
CN108014340A (zh) * 2011-04-12 2018-05-11 莫伊莱麦屈克斯公司 用于预防或治疗以成纤维细胞异常增殖及细胞外基质沉积为特征的疾病的组合物和方法
WO2013134636A1 (en) 2012-03-09 2013-09-12 Purdue Research Foundation Compositions and methods for delivery of kinase inhibiting peptides
MX344635B (es) * 2012-03-23 2017-01-04 Amicrobe Inc Composiciones y usos de materiales antimicrobianos con propiedades compatibles con el tejido.
US20140072613A1 (en) * 2012-09-10 2014-03-13 Cynthia Lander Compositions and Methods for Treating Cutaneous Scarring
WO2016061145A1 (en) * 2014-10-13 2016-04-21 Symic Biomedical, Inc. Synthetic proteoglycans for preventing tissue adhesion
MX2017006372A (es) * 2014-11-17 2017-08-21 Moerae Matrix Inc Composiciones y metodos para prevenir o tratar enfermedades, condiciones o procesos caracterizados por proliferacion de fibroblasto aberrante y matrix extracelular.
KR20170102900A (ko) 2015-01-08 2017-09-12 모레 매트릭스 인코포레이티드 Mk2 저해제 펩타이드의 제형
CA2978941A1 (en) 2015-03-12 2016-09-15 Moerae Matrix, Inc. Use of mk2 inhibitor peptide-containing compositions for treating non-small cell lung cancer with same
CN110740744A (zh) 2017-04-06 2020-01-31 艾麦克罗比公司 性能和安全性增强的局部施用的抗微生物剂的组合物和应用
RU2741247C1 (ru) * 2020-10-13 2021-01-22 федеральное государственное бюджетное образовательное учреждение высшего образования "Ростовский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО РостГМУ Минздрава России) Способ профилактики перитонеальных спаек женского таза

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1521000A (en) 1975-06-13 1978-08-09 Syntex Puerto Rico Inc Inhalation device
US4227522A (en) 1978-09-05 1980-10-14 Syntex Puerto Rico, Inc. Inhalation device
US4192309A (en) 1978-09-05 1980-03-11 Syntex Puerto Rico, Inc. Inhalation device with capsule opener
DK172541B1 (da) 1982-10-08 1998-12-07 Glaxo Group Ltd Apparat til administrering af medikamenter til patienter og en medikamentpakning til brug i apparatet
US4778054A (en) 1982-10-08 1988-10-18 Glaxo Group Limited Pack for administering medicaments to patients
AU591152B2 (en) 1985-07-30 1989-11-30 Glaxo Group Limited Devices for administering medicaments to patients
JPH05963A (ja) 1990-04-13 1993-01-08 Toray Ind Inc ポリペプチド類組成物
AU4115693A (en) 1992-04-24 1993-11-29 Sri International In vivo homologous sequence targeting in eukaryotic cells
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
DK0733059T3 (da) 1993-12-09 2000-10-16 Univ Jefferson Forbindelser og fremgangsmåder til site-rettede mutationer i eukaryote celler
AU2003260668A1 (en) 2002-04-01 2003-10-20 Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Biological affinity based delivery systems
US8008093B2 (en) * 2004-12-02 2011-08-30 The University Of North Carolina At Chapel Hill Inhibition of Hsp27 phosphorylation for the treatment of blistering disorders
JP5116663B2 (ja) * 2005-04-15 2013-01-09 アリゾナ バイオメディカル リサーチ コミッション 転移癌の処置のための治療用ペプチド
US20080293640A1 (en) * 2007-01-10 2008-11-27 Arizona Board of Regents, A body Corporate, of the State of Arizona, acting for and on behalf of Polypeptide inhibitors of HSP27 kinase and uses therefor
ES2594281T3 (es) * 2007-01-10 2016-12-19 Purdue Research Foundation Inhibidores polipeptídicos de HSP27 quinasa y usos de los mismos
WO2008109794A2 (en) * 2007-03-08 2008-09-12 Tufts Medical Center The role of the mk2 pathway in treating fibrosis and scarring
DK2185698T3 (en) * 2007-08-07 2015-07-27 Purdue Research Foundation Kinase Inhibitors and Uses thereof
WO2009123759A2 (en) * 2008-04-02 2009-10-08 Moerae Matrix, Inc. Therapeutic uses of biocompatible biogel compositions

Similar Documents

Publication Publication Date Title
US6506731B1 (en) Elastin peptide analogs and methods of using same
US7786084B2 (en) Treatment of burns
JP5384342B2 (ja) 癌のような変更された細胞遊走に関連する障害の治療のための薬理学的活性を有するペプチド
DK2402369T3 (en) Peptide fragments for inducing synthesis of extracellular matrix proteins
US20080299180A1 (en) Peptides based on the sequence of human lactoferrin and their use
JP2022513223A5 (enExample)
RU2699712C1 (ru) Антимикробный пептид и его применение
JP2011518179A5 (enExample)
JP2019533722A5 (enExample)
US6794362B1 (en) Asparagine containing elastin peptide analogs
RU2012136530A (ru) Новые соединения, влияющие на пищевое поведение
KR20110095867A (ko) 유착 치료 또는 예방용 폴리펩티드
JP2006506942A5 (enExample)
JP2020507623A5 (enExample)
Saklani et al. Laminin mimetic angiogenic and collagen peptide hydrogel for enhance dermal wound healing
WO2017101144A1 (zh) 脂肪组织靶向多肽及其制备方法和应用
CN108530527B (zh) 一种多肽oa-gl21及其提纯方法与应用
JP2003528885A (ja) インシュリン強化ペプチド
CA2415225A1 (en) Composition and method for enhancing elasticity of tissue
AU2001275018A1 (en) Composition and method for enhancing elasticity of tissue
JP2016520592A (ja) マルファン症候群および関連障害の処置におけるアンジオテンシンペプチド
RU2458069C2 (ru) Выделенный пептид для усиления ранозаживляющей активности кератиноцитов, композиция для заживления ран у млекопитающего и лекарственное средство для применения при заживлении ран у млекопитающего
JP2019038772A5 (enExample)
RU2010128602A (ru) Циклический белок, не содержащий остатков цистеина
JP2011503137A (ja) 新規のアルギニン置換ペプチド及びその使用